Skip to main content
. 2011 Sep 8;2011:570170. doi: 10.1155/2011/570170

Table 2.

The effect of neonatal vitamin A supplementation (VAS) on weight and length parameters at 6 and 12 months of age overall and by sex.

All Boys Girls
VAS Placebo Difference
(95% CI)
RR
(95% CI)
VAS Placebo Difference
(95% CI)
RR
(95% CI)
VAS. A Placebo Difference (95% CI) RR
(95% CI)
6 months of age

N 308 308 149 150 159 158
Age at measurement in days 181 182 181 182 181 182
Length in cm 64.4 64.3 0.1
(−0.4; 0.49)
65.3 65 0.3
(−0.4; 0.9)
63.6 63.7 −0.1
(−0.7; 0.4)
Length for age z-score (LAZ) −0.97 −1.01 0.05
(−0.12; 0.22)
−1.04 −1.18 0.14
(−0.12; 0.41)
−0.90 −0.86 −0.04
(−0.25; 0.17)
Stunted (LAZ <−2) 16% 16% 1.00
(0.69; 1.44)
19% 24% 0.81
(0.52; 1.25)
12% 8% 1.57
(0.79; 3.13)
Weight in kg 7.59 7.61 −0.02
(−0.18; 0.14)
7.83 7.96 −0.13
(−0.35; 0.10)
7.36 7.28 0.08
(−0.13; 0.30)
Weight for age z-score (WAZ) −0.05 −0.03 −0.02
(−0.18; 0.14)
−0.12 0.00 −0.12
(−0.36; 0.12)
0.02 −0.06 0.08
(−0.16; 0.31)
Underweight (WAZ <−2) 3% 2% 1.66
(0.61; 4.53)
3% 2% 1.68
(0.42; 0.6.90)
3% 2% 1.66
(0.40; 6.81)

12 months of age

N 224 244 102 121 122 123
Age at measurement in days 362 363 359 363 365 363
Length in cm 71.7 71.6 0.1
(−0.3; 0.6)
72.4 72.1 0.2
(−0.4; 0.9)
71.1 71.0 0.1
(−0.5; 0.7)
Length for age z-score (LAZ) −1.20 −1.30 0.10
(−0.08; 0.28)
−1.32 −1.48 0.16
(−0.12; 0.43)
−1.11 −1.13 0.02
(−0.21; 0.25)
Stunted (LAZ <−2) 21% 24% 0.85
(0.60; 1.19)
25% 34% 0.75
(0.49; 1.14)
16% 15% 1.12
(0.63; 2.01)
Weight in kg 8.86 8.79 0.08
(−0.14; 0.29)
9.11 9.01 0.10
(−0.20; 0.39)
8.66 8.57 0.09
(−0.22; 0.41)
Weight for age z-score (WAZ) −0.44 −0.54 0.10
(−0.11; 0.31)
−0.54 −0.66 0.12
(−0.17, 0.42)
−0.37 −0.43 0.06
(−0.23, 0.35)
Underweight (WAZ <−2) 7% 9% 0.74
(0.39, 1.38)
5% 13% 0.39
(0.14, 1.04)
8% 6% 1.44
(0.57, 3.66)